CCT6A sustained the oncogenic arm of TGF-β signaling and functioned as a potent promoter of TGF-β-induced metastasis of NSCLC cells, blocking SMAD2-SMAD4 interaction (Ying et al., 2017). Here, SMAD4 is linked to non-small cell lung carcinoma.